Welcome to LookChem.com Sign In|Join Free
  • or
5-(3,4-(DIMETHOXY)PHENYL)-1,3-dihydro-2H-indol-3-ol, also known as PNU-99,194, is a synthetic indole derivative and a selective 5-HT1A receptor agonist. It is a chemical compound derived from serotonin and has been studied for its potential therapeutic effects in various conditions, including anxiety, depression, cognitive dysfunction, and neurodegenerative disorders. PNU-99,194 holds promise as a treatment option in the field of mental health and neurology.

190064-28-9

Post Buying Request

190064-28-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

190064-28-9 Usage

Uses

Used in Pharmaceutical Industry:
PNU-99,194 is used as a therapeutic agent for the treatment of anxiety disorders. As a selective 5-HT1A receptor agonist, it modulates the serotonin system, which plays a crucial role in regulating mood and anxiety levels. Its agonistic action on the 5-HT1A receptor helps alleviate anxiety symptoms and improve overall mental well-being.
Used in Neurology:
PNU-99,194 is used as a potential treatment for depression. 5-(3 4-(DIMETHOXY)PHENYL)-1 3-'s interaction with the 5-HT1A receptor has been shown to have antidepressant effects, providing relief from depressive symptoms and improving mood regulation.
Used in Cognitive Enhancement:
PNU-99,194 is used as a cognitive enhancer to improve cognitive function in individuals with cognitive dysfunction. Its agonistic action on the 5-HT1A receptor has been linked to enhanced cognitive performance, memory, and learning abilities.
Used in Neurodegenerative Disorders:
PNU-99,194 is used as a potential treatment for neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Its agonistic effects on the 5-HT1A receptor have shown promise in modulating neurobehavioral responses and slowing down the progression of neurodegenerative conditions.
Used in Research and Development:
PNU-99,194 is used as a research tool in the development of new therapeutic agents targeting the serotonin system. Its selective agonistic action on the 5-HT1A receptor makes it a valuable compound for studying the role of serotonin in various mental health and neurological conditions, paving the way for the discovery of novel treatments.

Check Digit Verification of cas no

The CAS Registry Mumber 190064-28-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,0,0,6 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 190064-28:
(8*1)+(7*9)+(6*0)+(5*0)+(4*6)+(3*4)+(2*2)+(1*8)=119
119 % 10 = 9
So 190064-28-9 is a valid CAS Registry Number.
InChI:InChI=1/C14H16O4/c1-17-13-4-3-9(7-14(13)18-2)10-5-11(15)8-12(16)6-10/h3-4,7,10H,5-6,8H2,1-2H3

190064-28-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(3,4-Dimethoxyphenyl)cyclohexane-1,3-dione

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:190064-28-9 SDS

190064-28-9Relevant academic research and scientific papers

Phenylethanolamine compounds useful as beta 3 agonists, process for producing the same, and intermediates in the production of the same

-

, (2008/06/13)

PCT No. PCT/JP96/03097 Sec. 371 Date Apr. 24, 1998 Sec. 102(e) Date Apr. 24, 1998 PCT Filed Oct. 24, 1996 PCT Pub. No. WO97/15549 PCT Pub. Date May 1, 1997The present invention relates to phenylethanolamine compounds represented by general formula [I]: (where R1 represents hydrogen or halogen; R2 represents hydrogen, hydroxy, lower alkoxy, lower alkoxy substituted with one or two lower alkoxycarbonyl or carboxy groups, lower alkoxy substituted with lower alkylaminocarbonyl which may be substituted with lower alkoxy, lower alkoxy substituted with cyclic aminocarbonyl of 4 to 6 carbon atoms, lower alkoxycarbonyl or carboxy; R3 represents hydrogen, hydroxy, lower alkoxy or lower alkoxy substituted with one or two lower alkoxycarbonyl or carboxy groups; R2 and R3 may be bonded to each other to form methylenedioxy substituted with carboxy or lower alkoxycarbonyl; and m and n are 0 or 1), and their pharmacologically acceptable salts, which have a potent beta 3 adrenergic stimulating effect and high beta 3 adrenergic receptor selectivity, as well as to processes for their production and intermediates in their production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 190064-28-9